BCG and New Preventive Tuberculosis Vaccines: Implications for Healthcare Workers
Open Access
- 26 April 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 62 (suppl 3) , S262-S267
Abstract
Healthcare workers (HCWs) are at high risk of Mycobacterium tuberculosis ( Mtb ) infection and tuberculosis disease, but also play a crucial role in implementing healthcare. Preexposure tuberculosis vaccination, including revaccination with BCG, might benefit Mtb -uninfected HCWs, but most HCWs in tuberculosis-endemic countries are already sensitized to mycobacteria. A new postexposure tuberculosis vaccine offers greatest potential for protection, in the setting of repeated occupational Mtb exposure. Novel strategies for induction of mycobacteria-specific resident memory T cells in the lung by aerosol administration, or induction of T cells with inherent propensity for residing in mucosal sites, such as CD1-restricted T cells and mucosa-associated innate T cells, should be explored. The need for improved protection of HCWs against tuberculosis disease is clear. However, health systems in tuberculosis-endemic countries would need significantly improved occupational health structures to implement a screening and vaccination strategy for HCWs.Keywords
Funding Information
- Wellcome Trust
This publication has 60 references indexed in Scilit:
- Making wider use of the world's most widely used vaccine: Bacille Calmette–Guérin revaccination reconsideredJournal of The Royal Society Interface, 2013
- Identifying Predictors of Interferon-γ Release Assay Results in Pediatric Latent Tuberculosis: A Protective Role of Bacillus Calmette-Guérin?: A pTB-NET Collaborative StudyAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Long-lived epithelial immunity by tissue-resident memory T (TRM) cells in the absence of persisting local antigen presentationProceedings of the National Academy of Sciences, 2012
- Risk of Progression to Active Tuberculosis Following Reinfection With Mycobacterium tuberculosisClinical Infectious Diseases, 2012
- The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infectionJournal of Clinical Investigation, 2012
- Profound early control of highly pathogenic SIV by an effector memory T-cell vaccineNature, 2011
- Prevalence and risk factors of latent tuberculosis infection among health care workers in MalaysiaBMC Infectious Diseases, 2011
- Rapid Molecular Detection of Tuberculosis and Rifampin ResistanceNew England Journal of Medicine, 2010
- The influence of previous exposure to environmental mycobacteria on the interferon-gamma response to bacille Calmette–Guérin vaccination in southern England and northern MalawiClinical and Experimental Immunology, 2006
- Serial Testing of Health Care Workers for Tuberculosis Using Interferon-γ AssayAmerican Journal of Respiratory and Critical Care Medicine, 2006